Trade Mark Journal No.2026/039 25 September 2026

WO0000001936636 (9,42,45)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:14 July 2026
Date of designation in the UK: 14 July 2026
Image for mark 1936636_TIF RIVERCELL

International priority date claimed: 16 January 2026 (United States of America) (99599095)
Class 9
Downloadable and recorded software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded computer software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded software for generating data in the fields of cell biology, biotechnology, and drug discovery; downloadable and recorded computer software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery; laboratory equipment, namely, liquid handlers in the nature of laboratory robots, microscopes and incubators.
Class 42
Scientific research and development services in the fields of cell biology, biotechnology, and drug discovery; conducting scientific research in the fields of cell biology, biotechnology, and drug discovery; conducting cell perturbation experiments for scientific research and drug discovery purposes, namely, scientific research and drug discovery services; data generation, curation, and analysis in the nature of scientific research services in the fields of cell biology, biotechnology, and drug discovery; providing temporary use of non-downloadable cloud-based software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; providing temporary use of non-downloadable cloud-based software for generating data in the fields of cell biology, biotechnology, and drug discovery; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery.
Class 45
Licensing of intellectual property rights in the fields of cell biology, biotechnology, and drug discovery.

Blossom Life Sciences SAS

Representative: J A Kemp France, 19 boulevard Malesherbes, F-75008 Paris, FRANCE